Format

Send to

Choose Destination
Paediatr Respir Rev. 2010 Sep;11(3):177-84. doi: 10.1016/j.prrv.2010.05.003. Epub 2010 Jun 16.

Early eradication of Pseudomonas aeruginosa in patients with cystic fibrosis.

Author information

1
Eudowood Division of Pediatric Respiratory Sciences, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287-2533, USA.

Abstract

Pseudomonas aeruginosa (Pa) is the predominant organism infecting the airways of patients with cystic fibrosis (CF). This organism has an armamentarium of survival mechanisms that allows it to survive in the CF airway. Since colonization and chronic infection with Pa is associated with poorer lung function and increased morbidity and mortality, therapies that can prevent infection could significantly improve the lives of patients with CF. Numerous studies have examined the effects of treatment on the eradication of Pa as a means to ameliorate disease. This article outlines the pathophysiology and clinical implication of Pa acquisition, and reviews the existing treatment regimens aimed at early eradication of Pa in patients with CF.

PMID:
20692633
PMCID:
PMC4001925
DOI:
10.1016/j.prrv.2010.05.003
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center